Immune Globulin Intravenous (Human)

intravenous immunoglobulin · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Intravenous (Human), covering 2016-03-21 to 2016-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration [Phase 2]